KPC Pharmaceuticals,Inc. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	2,271	1,500	1,658	1,574
Trading Asset Securities	-	471.28	603.8	319.4	160.5
Cash & Short-Term Investments	2,759	2,742	2,103	1,978	1,735
Cash Growth	0.64%	30.36%	6.35%	14.01%	-4.68%
Accounts Receivable	-	3,855	3,225	2,625	2,011
Other Receivables	-	123.73	797.75	95.1	169.09
Receivables	-	3,979	4,022	2,720	2,180
Inventory	-	1,540	1,772	1,681	1,884
Other Current Assets	-	294.82	250.14	388.21	381.96
Total Current Assets	-	8,555	8,148	6,766	6,180
Property, Plant & Equipment	-	1,286	1,307	1,291	1,361
Long-Term Investments	-	305.46	319.61	320.61	278.24
Goodwill	-	1,503	1,503	91.73	91.73
Other Intangible Assets	-	412.22	441.97	355.98	408.88
Long-Term Deferred Tax Assets	-	258.28	269.12	245.6	233.83
Long-Term Deferred Charges	-	237.84	237	199.07	274.49
Other Long-Term Assets	-	53.12	69.83	161.17	64.98
Total Assets	-	12,611	12,295	9,432	8,893
Accounts Payable	-	1,056	936.78	977.12	1,239
Accrued Expenses	-	1,831	1,597	1,262	1,117
Short-Term Debt	-	658.04	725.49	912.76	641.75
Current Portion of Long-Term Debt	-	61.05	1	99.5	0.2
Current Portion of Leases	-	19.28	22.46	22.57	36.07
Current Income Taxes Payable	-	158.94	149.75	78.76	93.28
Current Unearned Revenue	-	83.32	102.63	186.37	74.09
Other Current Liabilities	-	1,624	329.7	350.01	284.76
Total Current Liabilities	-	5,491	3,865	3,889	3,485
Long-Term Debt	-	46.05	107.56	60	99.5
Long-Term Leases	-	48.59	44.24	44.77	50.47
Long-Term Unearned Revenue	-	229.92	224.09	207.58	245.34
Long-Term Deferred Tax Liabilities	-	21.65	24.28	10.64	15.42
Other Long-Term Liabilities	-	28.03	75.97	77.58	56.67
Total Liabilities	-	5,865	4,341	4,289	3,953
Common Stock	-	756.98	757.99	758.26	758.26
Additional Paid-In Capital	-	520.62	2,327	1,161	1,169
Retained Earnings	-	3,981	3,490	3,071	2,894
Treasury Stock	-	-	-10.42	-13.15	-26.3
Comprehensive Income & Other	-	-5.29	-1.62	6.3	-11.5
Total Common Equity	5,309	5,254	6,562	4,983	4,783
Minority Interest	-	1,493	1,392	159.5	156.98
Shareholders' Equity	6,856	6,746	7,954	5,143	4,940
Total Liabilities & Equity	-	12,611	12,295	9,432	8,893
Total Debt	1,693	833.02	900.74	1,140	828
Net Cash (Debt)	1,066	1,909	1,203	838.19	906.76
Net Cash Growth	-44.15%	58.73%	43.47%	-7.56%	-9.49%
Net Cash Per Share	1.40	2.53	1.58	1.12	1.20
Filing Date Shares Outstanding	756.98	756.98	757.11	758.13	758.26
Total Common Shares Outstanding	756.98	756.98	757.99	758.26	758.26
Working Capital	-	3,064	4,283	2,878	2,695
Book Value Per Share	7.01	6.94	8.66	6.57	6.31
Tangible Book Value	3,432	3,338	4,617	4,535	4,283
Tangible Book Value Per Share	4.53	4.41	6.09	5.98	5.65
Buildings	-	1,325	1,262	1,137	1,136
Machinery	-	1,058	1,011	988.66	980.07
Construction In Progress	-	76.46	100.51	64.65	43.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.